Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of Prevalence and Risk Factors of Persistent COVID-19 in Immunocompromised Patients
Sponsor: Maddalena Giannella
Summary
Spontaneous international multicenter retrospective and prospective observational study which objective is to evaluate the prevalence and risk factors of persistent SARS-CoV-2 infection within a population of hematology patients with humoral immunity deficiency.
Official title: Evaluation of Prevalence and Risk Factors of Persistent SARS-CoV-2 Infection in Immunocompromised Patients
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
204
Start Date
2024-03-01
Completion Date
2025-09-30
Last Updated
2025-03-27
Healthy Volunteers
No
Conditions
Interventions
Persisting SARS-CoV-2 infection
Prevalence of persisting SARS-CoV-2 infection among immunocompromised patients defined as the persistence or the recurrence of symptoms and signs (fever, dyspnea, hypoxemia, changes on chest-X ray or CT scan) and positive SARS-CoV-2 PCR ≥ 21 days after the time 0 (day of the first test positive for SARS-CoV-2 infection)
Locations (5)
Irccs Aoubo
Bologna, Italy
IRCCS Humanitas
Milan, Italy
IRCCS INMI L. Spallanzani
Roma, Italy
AOUI Verona
Verona, Italy
Hospital Virgen Macarena
Seville, Spain